NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $740 | -78.4% | 45,780 | -44.5% | 0.00% | -100.0% |
Q2 2023 | $3,427 | -38.4% | 82,552 | -10.8% | 0.00% | -33.3% |
Q1 2023 | $5,563 | -2.6% | 92,522 | +18.8% | 0.00% | 0.0% |
Q4 2022 | $5,712 | -99.9% | 77,886 | +2.6% | 0.00% | -50.0% |
Q3 2022 | $5,767,000 | +17.4% | 75,911 | +7.4% | 0.01% | +100.0% |
Q2 2022 | $4,911,000 | +3.1% | 70,652 | +22.9% | 0.00% | -25.0% |
Q1 2022 | $4,765,000 | -54.4% | 57,491 | -58.7% | 0.00% | +100.0% |
Q4 2021 | $10,442,000 | +23.2% | 139,044 | +90.6% | 0.00% | -50.0% |
Q3 2021 | $8,475,000 | -53.5% | 72,940 | -11.3% | 0.00% | -55.6% |
Q2 2021 | $18,235,000 | +119.0% | 82,204 | +30.5% | 0.01% | +125.0% |
Q1 2021 | $8,327,000 | -41.8% | 63,004 | -23.8% | 0.00% | -50.0% |
Q4 2020 | $14,304,000 | +137.5% | 82,658 | +52.8% | 0.01% | +100.0% |
Q3 2020 | $6,023,000 | -72.4% | 54,106 | -85.3% | 0.00% | -76.5% |
Q2 2020 | $21,805,000 | -35.5% | 367,715 | -26.7% | 0.02% | -37.0% |
Q1 2020 | $33,795,000 | -22.9% | 501,844 | -3.6% | 0.03% | +12.5% |
Q4 2019 | $43,854,000 | +28.4% | 520,396 | +14.0% | 0.02% | +14.3% |
Q3 2019 | $34,150,000 | +23.7% | 456,669 | +4.6% | 0.02% | +23.5% |
Q2 2019 | $27,600,000 | +39.6% | 436,501 | +6.3% | 0.02% | +30.8% |
Q1 2019 | $19,774,000 | +73137.0% | 410,516 | +50895.8% | 0.01% | – |
Q4 2018 | $27,000 | -98.2% | 805 | -97.2% | 0.00% | -100.0% |
Q3 2018 | $1,515,000 | +457.0% | 28,895 | +231.9% | 0.00% | – |
Q2 2018 | $272,000 | -26.7% | 8,706 | -48.8% | 0.00% | – |
Q1 2018 | $371,000 | -26.1% | 17,013 | -31.5% | 0.00% | – |
Q4 2017 | $502,000 | +122.1% | 24,840 | +119.3% | 0.00% | – |
Q3 2017 | $226,000 | +135.4% | 11,328 | +104.4% | 0.00% | – |
Q2 2017 | $96,000 | +100.0% | 5,541 | -7.4% | 0.00% | – |
Q1 2017 | $48,000 | -90.1% | 5,983 | -90.3% | 0.00% | -100.0% |
Q4 2016 | $484,000 | +4740.0% | 61,579 | +5105.3% | 0.00% | – |
Q3 2016 | $10,000 | +900.0% | 1,183 | +1083.0% | 0.00% | – |
Q2 2016 | $1,000 | -99.7% | 100 | -99.6% | 0.00% | -100.0% |
Q1 2016 | $376,000 | +9300.0% | 26,872 | +14504.3% | 0.00% | – |
Q4 2015 | $4,000 | – | 184 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |